RxDoctor Payments Data

Jodie Harper, MD

Geriatric Medicine · Indianapolis, INNPI 1003817297

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $19,364 of the $26,746 with a category attached, or 72.4%. Smith+Nephew accounts for 87.0% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $10,273 and has fallen 95.7% since, to $445 in 2025. Among geriatric medicine clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$26,746in general payments, 2019–2025

Across 125 payments — averaging $213.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$23K
  • AbbVie$1K
  • Integra Lifesciences Corporation$479
  • Organogenesis Inc.$289
  • Bioventus LLC$267
  • Kerecis Limited$249
  • plus $764 from 14 others

What the payments were for

  • Consulting fees$1,0004%
  • Speaking & faculty fees$19,36472%
  • Travel & lodging$2,2548%
  • Food & beverage$4,12915%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,746 in reported general payments places this provider in the 95th percentile of 70 geriatric medicine providers in Indiana.

See all geriatric medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$63,373
Medicare patients
164
Services billed
660

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Memantine Hcl158$4,853
Mirtazapine44$1,907
Buspirone Hcl85$1,812
Donepezil Hcl154$1,533
Desvenlafaxine Succinate ErDesvenlafaxine Succinate15$1,425
Sertraline Hcl140$920
Duloxetine Hcl32$853
Quetiapine Fumarate48$708
Divalproex Sodium18$648
Risperidone23$437
Escitalopram Oxalate39$387
Doxycycline Hyclate42$385
Citalopram HbrCitalopram Hydrobromide39$270
Mupirocin31$245
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$217

Paid to pharmacies, not to this prescriber.

Other geriatric medicine in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →